Analyst Research Report Snapshot

Title:

Crompton Greaves Ltd. | Q3FY13 Result Update

Price:

$35.00

Provider:

IndiaNivesh Securities Pvt Ltd

Date:

30 Jan 2013

Pages:

4

Type:

AcrobatPDF

Companies referenced:

CROM.NS

Available for Immediate Download
Summary:

Crompton Greaves Ltd. | Q3FY13 Result Update Poor show continues CG reported a consolidated top-line of Rs 29.7 bn against our expectations of Rs 29.7 bn. The company reported a net loss of ~Rs 1.9 bn against our PAT expectations of Rs 377 mn. The reported PAT margins were at negative 6.4% (vs. positive 2.5% a year ago). Outlook & Valuation: At CMP of Rs 108, CG is trading at FY13E and FY14E, P/E multiple of 28.5x and 17.9x, respectively. With all negatives surrounding the stock and the current unjustified rich valuations, we maintain our SELL rating on the stock with FY14E price target of Rs 86.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.